Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (630)	1/17/2005 4:28:57 AM
From: tuck	Respond to of 3722

Yup, had AGNT in the trickle portfolio and the original lock-up expiration hell portfolio. It was one of the worst performers in both. Sales went flat in 2001 and never (organically) recovered, despite new product offerings. The made an ill-fated buy of an Irish reagent and chromatography company that never helped; they later divested for a loss. Their stuff always seemed to me to have potential; Doctor Voodoo the Biofreak community's resident chemist, was less sure. So be sure your chemist friends are unequivocally enthusiastic should you decide to take a flyer on it. They used to sell for less than cash, but now they don't. Not a good trend when the stock price has been in a multiyear downtrend, too. Cheers, Tuck